Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US5811452A · kind A · utility
58Cited by
6References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 8, 1997 |
| Grant date | Sep 22, 1998 |
| Priority date | — |
| Expiry date | Jan 8, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to novel taxoids possessing strong reversing activities for drug-resistance associated with anti-cancer agents, the preparation of these reversal agents and pharmaceutical compositions thereof. The new taxoids of the present invention have the formula (I). ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.